Trial Profile
A Study Assessing the Efficacy and Safety of Bridging Therapy with Sodium Bemiparin at Therapeutic-Doses
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jul 2017
Price :
$35
*
At a glance
- Drugs Bemiparin sodium (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Therapeutic Use
- 23 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association.